KLTO
Price
$0.46
Change
-$0.01 (-2.13%)
Updated
Dec 18, 04:59 PM (EDT)
TRVI
Price
$4.16
Change
-$0.34 (-7.56%)
Updated
Dec 18, 04:59 PM (EDT)
91 days until earnings call
Ad is loading...

KLTO vs TRVI

Header iconKLTO vs TRVI Comparison
Open Charts KLTO vs TRVIBanner chart's image
Klotho Neurosciences
Price$0.46
Change-$0.01 (-2.13%)
Volume$350
CapitalizationN/A
Trevi Therapeutics
Price$4.16
Change-$0.34 (-7.56%)
Volume$11.43K
CapitalizationN/A
KLTO vs TRVI Comparison Chart
Loading...
KLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KLTO vs. TRVI commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KLTO is a Hold and TRVI is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (KLTO: $0.47 vs. TRVI: $4.50)
Brand notoriety: KLTO and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KLTO: 8% vs. TRVI: 117%
Market capitalization -- KLTO: $10.93M vs. TRVI: $345.9M
KLTO [@Biotechnology] is valued at $10.93M. TRVI’s [@Biotechnology] market capitalization is $345.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KLTO’s FA Score shows that 0 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • KLTO’s FA Score: 0 green, 5 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, TRVI is a better buy in the long-term than KLTO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KLTO’s TA Score shows that 7 TA indicator(s) are bullish while TRVI’s TA Score has 5 bullish TA indicator(s).

  • KLTO’s TA Score: 7 bullish, 3 bearish.
  • TRVI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KLTO is a better buy in the short-term than TRVI.

Price Growth

KLTO (@Biotechnology) experienced а +3.98% price change this week, while TRVI (@Biotechnology) price change was +67.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

TRVI is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRVI($346M) has a higher market cap than KLTO($10.7M). TRVI YTD gains are higher at: 235.821 vs. KLTO (-95.607).
KLTOTRVIKLTO / TRVI
Capitalization10.7M346M3%
EBITDAN/AN/A-
Gain YTD-95.607235.821-41%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash845KN/A-
Total Debt3.9MN/A-
TECHNICAL ANALYSIS
Technical Analysis
KLTOTRVI
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
41%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
51%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
39%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
23%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
19%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
11%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
KLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

KLTO and

Correlation & Price change

A.I.dvisor tells us that KLTO and KALA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KLTO and KALA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLTO
1D Price
Change %
KLTO100%
+6.01%
KALA - KLTO
27%
Poorly correlated
+1.31%
ZVSA - KLTO
24%
Poorly correlated
-2.43%
TRVI - KLTO
22%
Poorly correlated
+6.13%
KZIA - KLTO
22%
Poorly correlated
+2.10%
HOWL - KLTO
22%
Poorly correlated
-1.20%
More

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with EDIT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
+6.13%
EDIT - TRVI
37%
Loosely correlated
+2.70%
AURA - TRVI
32%
Poorly correlated
-2.47%
XERS - TRVI
32%
Poorly correlated
+1.19%
NTLA - TRVI
31%
Poorly correlated
-1.87%
BEAM - TRVI
31%
Poorly correlated
-1.21%
More